MPS Pharma Ltd. - Research Center
531686 ADVIKLA Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | - | - | 0.03 | - | - |
| Operating profit | -0.40 | -0.41 | -0.35 | -0.32 | -0.30 |
| Interest | - | - | - | - | - |
| Gross profit | -0.31 | -0.41 | -0.35 | -0.07 | -0.29 |
| EPS (Rs) | -0.19 | -0.25 | 0.08 | -0.15 | -0.28 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.09 | - | - | 0.25 | 0.01 |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | 0.02 | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.26 | 0.23 | 0.21 | 0.21 | 0.19 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.14 | 0.18 | 0.16 | 0.11 | 0.10 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.07 | 0.07 | 0.26 | 0.26 | 0.28 |
| Taxation | -0.01 | -0.01 | -0.76 | -0.03 | -0.04 |
| Net profit / loss | -0.37 | -0.48 | 0.15 | -0.29 | -0.53 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | - | -1093.52 | - | - |
| GPM (%) | - | - | -951.63 | - | - |
| NPM (%) | - | - | 407.07 | - | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis